ARTICLE | Company News
Alligator Bioscience, ImmuRx deal
February 25, 2008 8:00 AM UTC
Alligator will use its protein optimization technology to develop a CD40 agonist for use in ImmuRx's cancer adjuvant platform. ImmuRx will have rights to resulting products. Alligator will receive un...